Counselors in Glenolden, PA Accepting Medicare
3 Counselors found. Showing 1 - 3
 Paula M. Hilborn, MA, LPC Counselor Medicare: Not Enrolled in Medicare Practice Location: 420 S Scott Ave, Glenolden, PA 19036 Phone: 610-809-6155 |
Mrs. Season Apple, MS, LPC Counselor - Professional Medicare: Not Enrolled in Medicare Practice Location: 1033 Tremont Dr, Glenolden, PA 19036 Phone: 484-680-6243 |
Shannon Marie Kilroy, MS, LPC, LPCMH, NCC Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 112 W Oak Ln, Glenolden, PA 19036 Phone: 267-854-7715 Fax: 267-481-7172 |
News Archive
Also in Global Health: Child sexual abuse in Zimbabwe; dengue outbreak in Cape Verde; program reduces waste in Kenya slums
The Mail & Guardian examines how the "economic collapse" in Zimbabwe has contributed to rising numbers of children falling victims to sexual abuse. "A single clinic in the capital, Harare, says it has treated nearly 30,000 girls and boys who were abused in the past four years - an average of 20 per day." The article examines other contributing factors to the sexual abuse of children in Zimbabwe and a recent program that aims to make schools safe places for Zimbabwe's children (11/10).
Kids with silent malaria remain vulnerable to developing endemic Burkitt lymphoma
A study has found strong similarities between children with endemic Burkitt lymphoma — an aggressive cancer that attacks the body's defense system and children with silent malaria infection.
Phantom caries revealed?
Microcomputed tomography of teeth can detect demarcated radiolucencies below the enamel–dentin junction that are of noncarious origin, and can therefore be classified as possible developmental irregularities, show study results.
FDA approves Salix' METOZOLV ODT for treating diabetic gastroparesis
Salix Pharmaceuticals, Ltd. (NASDAQ:SLXP) today announced the U.S. Food and Drug Administration (FDA) has granted marketing approval for METOZOLV™ ODT (metoclopramide HCl) 5mg and 10mg orally disintegrating tablets. METOZOLV ODT is indicated for the relief of symptoms in adults associated with acute and recurrent diabetic gastroparesis and for the treatment of short-term therapy (4-12 weeks) for adults with symptomatic documented gastroesophageal reflux disease (GERD) who fail to respond to conventional therapy1.
› Verified 6 days ago